# PRP in ACLR to Prevent PTOA

> **NCT05412381** · PHASE3 · RECRUITING · sponsor: **Hospital for Special Surgery, New York** · enrollment: 56 (estimated)

## Conditions studied

- Anterior Cruciate Ligament Injuries
- Post-traumatic Osteoarthritis
- PRP

## Interventions

- **PROCEDURE:** platelet rich plasma (PRP) injection
- **PROCEDURE:** placebo saline injection

## Key facts

- **NCT ID:** NCT05412381
- **Lead sponsor:** Hospital for Special Surgery, New York
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-27
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05412381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05412381, "PRP in ACLR to Prevent PTOA". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05412381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*